Translational Research in the Time of COVID-19-Dissolving Boundaries

PLoS Pathog. 2020 Sep 30;16(9):e1008898. doi: 10.1371/journal.ppat.1008898. eCollection 2020 Sep.

Authors

Jonathan D Edgeworth^{1

2

3}, Rahul Batra^{1

2}, Gaia Nebbia^{1

2}, Karen Bisnauthsing^{1

2}, Eithne MacMahon^{1

2

3}, Malur Sudhanva^{3

4}, Sam Douthwaite^{1

2}, Simon Goldenberg^{1

2}, Geraldine O'Hara^{1

2}, Manu Shankar-Hari¹, Katie J Doores¹, Rocio Martinez-Nunez¹, Carolyn Hemsley^{1

2}, Nicholas M Price^{1

2}, Jill Lockett⁵, Robert I Lechler⁵, Stuart J D Neil¹, Michael H Malim^{1

5}

Affiliations

¹ Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
² Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
³ Viapath, London, United Kingdom.
⁴ Department of Virology, King's College Hospital, London, United Kingdom.
⁵ King's Health Partners, London, United Kingdom.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / epidemiology*
Hospitals
Humans
Pandemics
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Translational Research, Biomedical / organization & administration*
Translational Research, Biomedical / trends*

Grants and funding